These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17347917)

  • 21. Evaluation of Body Composition and Biochemical Parameters in Adult Phenylketonuria.
    Balci MC; Karaca M; Gunes D; Korbeyli HK; Selamioglu A; Gokcay G
    Nutrients; 2024 Oct; 16(19):. PubMed ID: 39408322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice.
    Yannicelli S; Medeiros DM
    J Inherit Metab Dis; 2002 Sep; 25(5):347-61. PubMed ID: 12408184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mineral status in children with phenylketonuria under treatment.
    Al-Qadreh A; Schulpis KH; Athanasopoulou H; Mengreli C; Skarpalezou A; Voskaki I
    Acta Paediatr; 1998 Nov; 87(11):1162-6. PubMed ID: 9846918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary intake and nutritional status of patients with phenylketonuria in Taiwan.
    Weng HL; Yang FJ; Chen PR; Hwu WL; Lee NC; Chien YH
    Sci Rep; 2020 Sep; 10(1):14537. PubMed ID: 32883979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased bone mineralization in children with phenylketonuria under treatment.
    Hillman L; Schlotzhauer C; Lee D; Grasela J; Witter S; Allen S; Hillman R
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S148-52. PubMed ID: 8828633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved Eating Behaviour and Nutrient Intake in Noncompliant Patients with Phenylketonuria after Reintroducing a Protein Substitute: Observations from a Multicentre Study.
    Green B; Rahman Y; Firman S; Adam S; Jenkinson F; Nicol C; Adams S; Dawson C; Robertson L; Dunlop C; Cozens A; Hubbard G; Stratton R
    Nutrients; 2019 Aug; 11(9):. PubMed ID: 31480383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new, low-volume protein substitute for teenagers and adults with phenylketonuria.
    MacDonald A; Lilburn M; Cochrane B; Davies P; Daly A; Asplin D; Hall SK; Cousins A; Chakrapani A; Robinson P; Lee P
    J Inherit Metab Dis; 2004; 27(2):127-35. PubMed ID: 15159643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
    Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex differences in body composition and bone mineral density in phenylketonuria: A cross-sectional study.
    Stroup BM; Hansen KE; Krueger D; Binkley N; Ney DM
    Mol Genet Metab Rep; 2018 Jun; 15():30-35. PubMed ID: 30023287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone mineral status in children with phenylketonuria--relationship to nutritional intake and phenylalanine control.
    McMurry MP; Chan GM; Leonard CO; Ernst SL
    Am J Clin Nutr; 1992 May; 55(5):997-1004. PubMed ID: 1570811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.
    Solverson P; Murali SG; Litscher SJ; Blank RD; Ney DM
    PLoS One; 2012; 7(9):e45165. PubMed ID: 23028819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
    Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
    Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Association of Therapy Adherence and Thyroid Function in Adult Patients with Phenylketonuria.
    Sumanszki C; Kiss E; Simon E; Galgoczi E; Soos A; Patocs A; Kovacs B; Nagy EV; Reismann P
    Ann Nutr Metab; 2019; 75(1):16-23. PubMed ID: 31242484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone mineral density is within normal range in most adult phenylketonuria patients.
    Lubout CMA; Arrieta Blanco F; Bartosiewicz K; Feillet F; Gizewska M; Hollak C; van der Lee JH; Maillot F; Stepien KM; Wagenmakers MAEM; Welsink-Karssies MM; van Spronsen FJ; Bosch AM
    J Inherit Metab Dis; 2020 Mar; 43(2):251-258. PubMed ID: 31587319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy compliance in children with phenylketonuria younger than 5 years: A cohort study.
    Walkowiak D; Bukowska-Posadzy A; Kałużny Ł; Ołtarzewski M; Staszewski R; Musielak M; Walkowiak J
    Adv Clin Exp Med; 2019 Oct; 28(10):1385-1391. PubMed ID: 31469949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria.
    Vernon HJ; Koerner CB; Johnson MR; Bergner A; Hamosh A
    Mol Genet Metab; 2010 Jul; 100(3):229-33. PubMed ID: 20418136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does impaired growth of PKU patients correlate with the strictness of dietary treatment? National Dutch PKU Steering Committee.
    van Spronsen FJ; Verkerk PH; van Houten M; Smit GP; van der Meer SB; Bakker HD; Sengers RC
    Acta Paediatr; 1997 Aug; 86(8):816-8. PubMed ID: 9307159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscle and Bone Health in Young Chilean Adults with Phenylketonuria and Different Degrees of Compliance with the Phenylalanine Restricted Diet.
    Rojas-Agurto E; Leal-Witt MJ; Arias C; Cabello JF; Bunout D; Cornejo V
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of metabolic control on bone quality in phenylketonuria and mild hyperphenylalaninemia.
    Porta F; Mussa A; Zanin A; Greggio NA; Burlina A; Spada M
    J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):345-50. PubMed ID: 21336059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.